High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinoma

BACKGROUND: The prognosis of non-small cell lung cancer (NSCLC) varies greatly depending on whether or not it can receive molecular-targeted drug treatment including epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). We investigated the clinical utility of C-reactive protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Hotta, Takamasa, Nakashima, Kazuhisa, Hata, Kojiro, Tsubata, Yukari, Isobe, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024849/
https://www.ncbi.nlm.nih.gov/pubmed/33841940
http://dx.doi.org/10.21037/jtd-20-3123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024849/
https://www.ncbi.nlm.nih.gov/pubmed/33841940
http://dx.doi.org/10.21037/jtd-20-3123

Ejemplares similares